Synthesis of Thieno[3,2-d]pyrimidine Derivatives through Sequential SNAr and Suzuki Reactions as Selective h-NTPDase Inhibitors

Gohar Zaman, Saif Ullah, Muhammad Uzair, Sania Batool, Haseen Ahmad, Farman Ullah, Julia Pelletier, Jean Sévigny, Jamshed Iqbal, Abbas Hassan

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

In this study various of thieno[3,2-d]pyrimidine derivatives have been synthesized by treating different secondary amines through aromatic nucleophilic substitution reaction (SNAr) followed by Suzuki reaction with aryl and heteroaryl boronic acids. A bis-Suzuki coupling was also performed to generate bis-aryl thienopyrimidine derivatives. The synthesized compounds were screened for the hydrolytic activity of h-NTPdase1, h-NTPdase2, h-NTPdase3, and h-NTPdase8. The compound N-benzyl-N-methyl-7-phenylthieno[3,2-d]pyrimidin-4-amine 3 j selectively inhibits the activity of h-NTPdase1 with IC50 value of 0.62±0.02 μM whereas, the compound 4 d was the most potent inhibitor of h-NTPdase2 with sub-micromolar IC50 value of 0.33±0.09 μM. Similarly, compounds 4 c and 3 b were found to be selective inhibitors for isozymes h-NTPdase3 (IC50=0.13±0.06 μM) and h-NTPdase8 (IC50=0.32±0.10 μM), respectively. The molecular docking study of the compounds with the highest potency and selectivity revealed the interactions with the important amino acid residues.

Original languageEnglish
Article numbere202300165
JournalChemMedChem
Volume18
Issue number14
DOIs
Publication statusPublished - Jul 17 2023
Externally publishedYes

Keywords

  • molecular docking studies
  • NTPDases
  • structure-activity relationships
  • Suzuki reaction
  • thienopyrimidine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • General Pharmacology, Toxicology and Pharmaceutics
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis of Thieno[3,2-d]pyrimidine Derivatives through Sequential SNAr and Suzuki Reactions as Selective h-NTPDase Inhibitors'. Together they form a unique fingerprint.

Cite this